| Value | Category | Cases | |
|---|---|---|---|
| 1 | Oral PrEP only | 365 |
52.7%
|
| 2 | 2 monthly Injectable (im) cabotegravir only | 323 |
46.7%
|
| 3 | DapiRing Only | 0 |
0%
|
| 4 | 6 monthly subcutaneous lenocapovir | 0 |
0%
|
| 5 | Oral PrEP and Injectable cabotegravir | 4 |
0.6%
|
| 96 | Other | 0 |
0%
|
| Sysmiss | 112 |